Topics

Wellness Market News: VSI, Mannatech Q3 Results, GoGenics, Hundred, Orgain Investments, One CBD Launch

11:42 EST 8 Nov 2019 | SCRIP

One CBD launches as opioid alternative; EMEA drives Mannatech sales; VSI slumps in final quarter before sale; $3.2m financing for...

      

Related Stories

 

Original Article: Wellness Market News: VSI, Mannatech Q3 Results, GoGenics, Hundred, Orgain Investments, One CBD Launch

NEXT ARTICLE

More From BioPortfolio on "Wellness Market News: VSI, Mannatech Q3 Results, GoGenics, Hundred, Orgain Investments, One CBD Launch"

Quick Search

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...